JNJ vs STEL · P/E 17, rev $49.37B vs P/E 18, $1.91B cap
Johnson & Johnson (JNJ) versus Stellar Bancorp, Inc. (STEL) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Stellar Bancorp, Inc. (STEL) is a banks - regional company listed on US.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
STEL does not have a complete income-statement cache yet.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. STEL currently screens at market cap $1.91B and trailing P/E 18.2.
Not investment advice. Open the JNJ and STEL stock pages for the full models.
Not investment advice.